Answers are grounded in this paper and cite their sources.
Scoping review evaluates personalized revascularization strategies in acute myocardial infarction, highlighting evolving roles for drug-coated balloons and non-culprit vessel treatment.
INTRODUCTION: Revascularization post myocardial infarction is a complex interplay of patient and anatomical factors. There are a growing number of interventional tools providing both physiological and anatomical delineation of disease burden which can help determine method and extent of revascularization. A tailored approach is required taking into consideration shared decision making, co-morbidities and evolving treatment options. AREAS COVERED: This review article explores the wide array of revascularization techniques of both the culprit lesion and non-culprit lesions in the setting of acute myocardial infarction. A scoping literature review was undertaken of the Pubmed database using key words highlighted below. EXPERT OPINION: Prompt and durable revascularization of the infarct-related coronary artery remains the cornerstone of treatment for acute myocardial infarction. Specifically, timely restoration of normal flow and implantation of a DES during the index procedure remains the gold standard; however, deferred treatment and novel devices such as DCB may have an emerging role. Despite much evidence, complete revascularization of non-culprit coronary artery disease in acute myocardial infarction is still the subject of contention.
No takes yet. Share an insight, caveat, or question.
Mandala et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: